New depression drug shows promise in phase 2 trial
NCT ID NCT06259526
First seen Nov 19, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tested a new drug called JS1-1-01 in 267 adults with moderate to severe depression. The goal was to see if it safely reduces depression symptoms better than a placebo. Researchers measured changes using standard depression rating scales.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Capital Medical University Affiliated Anding Hospital
Beijing, Beijing Municipality, China
-
Chongqing 11th People's Hospital
Chongqing, Chongqing Municipality, China
-
Chongqing Mental Health Center
Chongqing, Chongqing Municipality, China
-
Daqing Third Hospital
Daqing, Heilongjiang, China
-
Hebei Provincial Mental Health Center
Baoding, Hebei, China
-
Huzhou Third People's Hospital
Huzhou, Zhejiang, China
-
Jiangxi Provincial Psychiatric Hospital
Nanchang, Jiangxi, China
-
Jilin Provincial Neuropsychiatric Hospital
Siping, Jilin, China
-
Peking University Sixth Hospital
Beijing, Beijing Municipality, China
-
Shandong Provincial Mental Health Center
Jinan, Shandong, China
-
The Affiliated Brain Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
-
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
Tianjin Anding Hospital
Tianjin, Tianjin Municipality, China
-
Wuxi Mental Health Center
Wuxi, Jiangsu, China
-
Zhenjiang Mental Health Center
Zhenjiang, Jiangsu, China
-
Ürümqi Fourth People's Hospital
Ürümqi, Xinjiang, China
Conditions
Explore the condition pages connected to this study.